Clinical Trials Browser

Phase 1 × Recruiting × Methylprednisolone × Clear all

NCT06225310 2025-01-16

KPT-IST-391

Phase 1 Recruiting

Multiple Myeloma

NCT03110822 2023-11-01

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Phase 1 Recruiting

Multiple Myeloma